Actualités Decision Diagnostics Corporation (CE) - DECN | Actions OTCMarkets

The Rapid Rise of Alternet Systems, Inc. (OTCMKTS: ALYI)

July 6, 2020 -- Investorshub NewsWire -- via Microcap Daily -- BY JACOB WATSON -- Alternet Systems, Inc. (OTCMKTS: ALYI...

DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology

DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology GenViroTM Ant...

DECN SETS PLAN TO MAKE UPCOMING PATENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOV...

DECN SETS PLAN TO MAKE UPCOMING PATENT INFRINGEMENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOVERY...

DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN 7 DAYS, CLINICAL TRIALS IN MAY

DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN NEXT 7 DAYS, CLINICAL TRIALS TESTING TO BEGIN IN...

Withdrawal of Offering Statement Under Regulation a (1-a-w)

DECISION DIAGNOSTICS CORP. 2660 Townsgate Road, Suite 300 Westlake Village, CA...

Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)

Form 1-A Issuer Information FORM 1-A UNITED STATE SECURITIES AND EXCHANGE...

DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE

DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE GOVERNMENT...

DECN DISCUSSES ITS GENULTIMATE! TBG SYSTEM, OFFERING ELITE PERFORMANCE AND PREMIER UPGRADE PATH FOR 4+ MILLION LIFESCAN USERS

++ COMPANY HAS ALSO AGREED TO MANUFACTURE A HOUSE BRAND PRODUCT FOR A “BIG BOX” AND WILL PROVIDE A FORECAST AND PRICE...

DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court)

DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court) ...

DECN ENGAGES SECOND KOREAN MANUFACTURING PARTNER TO RAISE ITS FACTORY CAPACITY TWO MILLION BOXES OF "GEN" TEST STRIPS ANNUALLY

++ COMPANY ALSO READIES IMMINENT APPEAL IN THE JOHNSON & JOHNSON PATENT INFRINGEMENT MATTER WITH THE U.S. COURT OF APPEALS FOR THE FEDERAL...

DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATI...

DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATIONS ++ IP...

DECN RECEIVES CLINICAL TRIALS REPORT, ANTICIPATES FILING ITS FDA 510K APPLICATION FOR ITS GENCHOICE! TEST STRIP ON 12/21/2018

++ DECN TO LAUNCH GENCHOICE! PRODUCT IN SELECT INTERNATIONAL MARKETS JANUARY 2, 2019 AND TO FILE FOR CE MARK IN THE EU AND HEALTH CANADA APPROVAL...

DECN CEO KEITH M. BERMAN IS INTERVIEWED BY PRESTIGIOUS WALL STREET REPORTER WHO DESCRIBE COMPANY & PRODUCTS AS "GAME CHANGER"

WALL STREET REPORTER POSTS INTERVIEW ON ITS WEB SITE FOR ALL INTERESTED PARTIES TO LISTEN AND TO LEARN LOS ANGELES, CA -- November 27...

DECN RECEIVES COMPLETED CLINICAL TRIAL DATA, CHARTS AND SPREADSHEETS ESSENTIAL FOR ITS IMMINENT GENCHOICE! TEST STRIP

++ COMPANY TO BEGIN SALES IN INTERNATIONAL MARKETS WHILE THE U.S. FDA REVIEWS ITS 510K APPLICATION ++ Los Angeles, CA -- November 6, 2018...

DECN SET TO APPEAL UNFAIR RULING IN COURT'S TERMINATION OF THE DECN CASE AGAINST INDUSTRY GIANT JOHNSON & JOHNSON

COURT DECIDES AFTER 10 MONTHS TO MODIFY THE SEMINAL LEGAL QUESTION AT ISSUE, THEREBY HANDING J&J AN EASY VICTORY THEY DO NOT DESERVE AND HAVE...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Decision Diagnostics Corporation (CE) (DECN)

Outils de qualité professionnelle, pour des investisseurs individuels.

DECN Actualités

The Rapid Rise of Alternet Systems, Inc. (OTCMKTS: ALYI)

DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology

DECN SETS PLAN TO MAKE UPCOMING PATENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOV...

DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN 7 DAYS, CLINICAL TRIALS IN MAY

Withdrawal of Offering Statement Under Regulation a (1-a-w)

Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)

DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE

DECN DISCUSSES ITS GENULTIMATE! TBG SYSTEM, OFFERING ELITE PERFORMANCE AND PREMIER UPGRADE PATH FOR 4+ MILLION LIFESCAN USERS

DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court)

DECN ENGAGES SECOND KOREAN MANUFACTURING PARTNER TO RAISE ITS FACTORY CAPACITY TWO MILLION BOXES OF "GEN" TEST STRIPS ANNUALLY

DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATI...

DECN RECEIVES CLINICAL TRIALS REPORT, ANTICIPATES FILING ITS FDA 510K APPLICATION FOR ITS GENCHOICE! TEST STRIP ON 12/21/2018

DECN CEO KEITH M. BERMAN IS INTERVIEWED BY PRESTIGIOUS WALL STREET REPORTER WHO DESCRIBE COMPANY & PRODUCTS AS "GAME CHANGER"

DECN RECEIVES COMPLETED CLINICAL TRIAL DATA, CHARTS AND SPREADSHEETS ESSENTIAL FOR ITS IMMINENT GENCHOICE! TEST STRIP

DECN SET TO APPEAL UNFAIR RULING IN COURT'S TERMINATION OF THE DECN CASE AGAINST INDUSTRY GIANT JOHNSON & JOHNSON

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Decision Diagnostics Corporation (CE) (DECN) Actualités

Decision Diagnostics Corporation (CE) (DECN)

Outils de qualité professionnelle, pour des investisseurs individuels.

DECN Actualités

The Rapid Rise of Alternet Systems, Inc. (OTCMKTS: ALYI)

DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology

DECN SETS PLAN TO MAKE UPCOMING PATENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOV...

DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN 7 DAYS, CLINICAL TRIALS IN MAY

Withdrawal of Offering Statement Under Regulation a (1-a-w)

Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)

DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE

DECN DISCUSSES ITS GENULTIMATE! TBG SYSTEM, OFFERING ELITE PERFORMANCE AND PREMIER UPGRADE PATH FOR 4+ MILLION LIFESCAN USERS

DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court)

DECN ENGAGES SECOND KOREAN MANUFACTURING PARTNER TO RAISE ITS FACTORY CAPACITY TWO MILLION BOXES OF "GEN" TEST STRIPS ANNUALLY

DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATI...

DECN RECEIVES CLINICAL TRIALS REPORT, ANTICIPATES FILING ITS FDA 510K APPLICATION FOR ITS GENCHOICE! TEST STRIP ON 12/21/2018

DECN CEO KEITH M. BERMAN IS INTERVIEWED BY PRESTIGIOUS WALL STREET REPORTER WHO DESCRIBE COMPANY & PRODUCTS AS "GAME CHANGER"

DECN RECEIVES COMPLETED CLINICAL TRIAL DATA, CHARTS AND SPREADSHEETS ESSENTIAL FOR ITS IMMINENT GENCHOICE! TEST STRIP

DECN SET TO APPEAL UNFAIR RULING IN COURT'S TERMINATION OF THE DECN CASE AGAINST INDUSTRY GIANT JOHNSON & JOHNSON

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités